Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/29/1999 | WO1999037674A1 Secreted proteins and polynucleotides encoding them |
07/29/1999 | WO1999037673A2 Antifreeze protein |
07/29/1999 | WO1999037665A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof |
07/29/1999 | WO1999037662A1 Spoil protein and nucleic acid molecules and uses therefor |
07/29/1999 | WO1999037660A1 Meth1 and meth2 polynucleotides and polypeptides |
07/29/1999 | WO1999037331A1 Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein |
07/29/1999 | WO1999037330A1 Method for determining gene essentiality in a pathogen |
07/29/1999 | WO1999037325A2 Method for treating acute intermittent porphyria (aip) and other porphyric diseases |
07/29/1999 | WO1999037324A1 Modified enzymes and their use for peptide synthesis |
07/29/1999 | WO1999037313A1 Immune effector cell hybrids |
07/29/1999 | WO1999037299A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer |
07/29/1999 | WO1999037143A2 Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei |
07/29/1999 | WO1999037142A1 Method for producing transgenic animals |
07/29/1999 | WO1999037139A1 Sesquiterpene synthases from grand fir abies grandis, and methods of use |
07/29/1999 | WO1999031227A3 NOVEL PEPTIDE, apoEp1.B, COMPOSITIONS AND USES THEREOF |
07/29/1999 | WO1999031219A3 Method for decomposing biological material |
07/29/1999 | WO1999031131A3 Mammalian calcitonin-like polypeptide-1 |
07/29/1999 | WO1999028471A3 ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE |
07/29/1999 | WO1999028449A3 Yac vectors |
07/29/1999 | WO1999027135A3 Method for identifying and inhibiting functional nucleic acid molecules in cells |
07/29/1999 | WO1999025862A3 Chimeric viral packaging signal without gag gene sequences |
07/29/1999 | WO1999025825A3 EXTENDED cDNAs FOR SECRETED PROTEINS |
07/29/1999 | WO1999024605A3 Dna with promoter activity for cell cycle genes |
07/29/1999 | WO1999023231A3 Modification of the tocopherol content of transgenic plants |
07/29/1999 | WO1999020755A3 Novel cytokine receptors |
07/29/1999 | WO1999019476A3 NON-MAMMALIAN MESODERM INDUCTION EARLY RESPONSE (nm-MIER) GENE FAMILY |
07/29/1999 | WO1999019348A9 Laminins and uses thereof |
07/29/1999 | WO1999018204A3 HUMAN PROTEINS HAVING SECRETORY SIGNAL SEQUENCES AND cDNAS ENCODING THESE PROTEINS |
07/29/1999 | WO1999014356A3 P53-induced apoptosis |
07/29/1999 | WO1998059063A3 Bovine adenovirus type 3 genome |
07/29/1999 | WO1998050530A3 Enzymatic nucleic acids: synthesis, selection and use |
07/29/1999 | WO1995030750A8 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
07/29/1999 | DE19802792A1 Inhibiting DNA modulation caused by p53 mutant, useful for treatment of cancer |
07/29/1999 | CA2431846A1 Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors |
07/29/1999 | CA2320624A1 Mutants of il-16, processes for their production, and their use |
07/29/1999 | CA2319209A1 Promoter and regulator sequences ha ds10 g1: a gene lea of sunflower exclusively expressed in seeds since the maturation phase. |
07/29/1999 | CA2319208A1 Orphan receptors |
07/29/1999 | CA2319160A1 Monoclonal antibody anti .alpha.v-integrin and its use to inhibit .alpha.v.beta.6-integrin attachment to fibronectin |
07/29/1999 | CA2319148A1 Methods for identifying therapeutic targets |
07/29/1999 | CA2319141A1 Porcine reproductive and respiratory syndrome oral vaccine production in plants |
07/29/1999 | CA2319121A1 Use of inhibitors for the treatment of rtk-hyperfunction-induced disorders, particularly cancer |
07/29/1999 | CA2319118A1 Frozen food product |
07/29/1999 | CA2319115A1 Methods for identifying antimicrobial peptides that interact with enoyl acp reductase |
07/29/1999 | CA2319109A1 Meth1 and meth2 polynucleotides and polypeptides |
07/29/1999 | CA2319076A1 Expression of the insl4 gene in human embryonic bone tissues and applications |
07/29/1999 | CA2319021A1 Method and device for cell lysis |
07/29/1999 | CA2318987A1 Immune effector cell hybrids |
07/29/1999 | CA2318979A1 Antigen-specific cells, methods of generating these cells and uses thereof |
07/29/1999 | CA2318935A1 Phagocytosis genes and uses thereof |
07/29/1999 | CA2318869A1 Antifreeze protein |
07/29/1999 | CA2318816A1 Ligand receptors and uses therefor |
07/29/1999 | CA2318751A1 Method of isolation of rna-binding compounds |
07/29/1999 | CA2318743A1 Novel molecules of the tnf receptor superfamily and uses therefor |
07/29/1999 | CA2318727A1 Spoil protein and nucleic acid molecules and uses therefor |
07/29/1999 | CA2318405A1 Antibodies to death receptor 4(dr4) and uses thereof |
07/29/1999 | CA2318403A1 Human orthologues of wart |
07/29/1999 | CA2318352A1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
07/29/1999 | CA2318313A1 Inhibition of dna modulation caused by mutated p53 |
07/29/1999 | CA2318303A1 Secreted proteins and polynucleotides encoding them |
07/29/1999 | CA2318070A1 Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei |
07/29/1999 | CA2317920A1 Human calcineurin b-like protein |
07/29/1999 | CA2317839A1 Inhibition of cytokine production |
07/29/1999 | CA2317727A1 Multipurpose antibody derivatives |
07/29/1999 | CA2317704A1 Assessing risk for integrin antagonist/agonist mediated diseases |
07/29/1999 | CA2317650A1 Gene expression methods for screening compounds |
07/29/1999 | CA2317492A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof |
07/29/1999 | CA2314677A1 Asthma related genes |
07/29/1999 | CA2314246A1 The use of consensus sequences for targeted homologous gene isolation and recombination in gene families |
07/28/1999 | EP0931837A1 Method for producing phytase |
07/28/1999 | EP0931836A1 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
07/28/1999 | EP0931835A2 Method for cloning and producing the PmeI restriction endonuclease |
07/28/1999 | EP0931834A2 Echinocandin binding domain of 1,3-Beta-glucan synthase |
07/28/1999 | EP0931833A2 Method of producing L-serine fermentation |
07/28/1999 | EP0931830A2 Cytopathic viruses for therapy and phophylaxis of neoplasia |
07/28/1999 | EP0931793A1 Monoclonal antibody specific for the activated coagulation factor VII (FVIIa) and its use |
07/28/1999 | EP0931262A1 Biochemical markers of the human endometrium |
07/28/1999 | EP0931165A1 Measurement of gene expression profiles in toxicity determination |
07/28/1999 | EP0931162A1 Production of a multimeric protein by cell fusion method |
07/28/1999 | EP0931159A2 Non-mammalian dna virus having an altered coat protein |
07/28/1999 | EP0931158A1 An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
07/28/1999 | EP0931157A1 Retroviral vectors |
07/28/1999 | EP0931156A2 Gene expression and delivery systems and uses |
07/28/1999 | EP0931155A1 Enhanced transgene expression in a population of monocot cells employing scaffold attachment regions |
07/28/1999 | EP0931154A1 Orpinomyces cellulases and coding sequences |
07/28/1999 | EP0931153A1 Fungal lichenase and coding sequences |
07/28/1999 | EP0931152A2 Crystal structures of a protein tyrosine kinase |
07/28/1999 | EP0931151A1 Thermostable nucleic acid polymerase from thermococcus gorgonarius |
07/28/1999 | EP0931150A2 Genetic control of fruit ripening |
07/28/1999 | EP0931149A2 A novel haemopoietin receptor and genetic sequences encoding same |
07/28/1999 | EP0931148A1 Fibroblast growth factor homologs |
07/28/1999 | EP0931147A1 ANTI-ErbB2 ANTIBODIES |
07/28/1999 | EP0931146A1 Rdgb-proteins |
07/28/1999 | EP0931145A1 Ptx sensitive g proteins, the production and use thereof |
07/28/1999 | EP0931144A1 Novel human phospholemman-like protein |
07/28/1999 | EP0931143A1 Production of recombinant peptide by transgenic fish |
07/28/1999 | EP0931140A1 Catalases |
07/28/1999 | EP0931096A2 HT m4?, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
07/28/1999 | EP0931093A1 Helicobacter pylori live vaccine |
07/28/1999 | EP0931092A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
07/28/1999 | EP0931089A1 A method of separating a two phase system |